Projected 19% earnings growth in 2026, yet trades at under 12x PE 2026. Has a robust drug pipeline.
Stock price when the opinion was issued
As of Jul 24, 2026. Market Open.
The momentum has broken badly and has a high PE. But he entered this on a rebound that has momentum. Despite an upgrade today, he doesn't see a green light ahead.
Build your watch list
Sign in to track investmentsyou care about
LDIC
Stockchase Premium
Scotia Wealth Management
Stockchase
CNBC
Projected 19% earnings growth in 2026, yet trades at under 12x PE 2026. Has a robust drug pipeline.